Equity Neuroscience Neuroscience

Donanemab and lecanemab in Alzheimer's disease treatment: A narrative review of clinical trials and discussion of implications for patient access

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →